Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Procalcitonin as a Marker of Infection in Cancer Patients

NCT01227109 is registered in ClinicalTrials.gov with Herlev Hospital as lead sponsor.

NCT NCT01227109
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01227109 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Procalcitonin as a Marker of Infection in Cancer Patients
Lead sponsor
Herlev Hospital
Phase
Observational
Overall status
Unknown status
Start date
February 28, 2011
Completion date
October 31, 2012
Enrollment
80 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

c reactive protein, cancer, infections, procalcitonin